How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1122332

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Medicines have important health benefits but can also lead to harm. When new safety concerns arise, national regulatory agencies issue warnings to health professionals and the public. These warnings differ between countries, but no research has compared the effectiveness of different approaches. This study compares safety advisories on medicines in Australia, Canada, the United States, and the European Union in order to identify how to best protect public health.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $1,002,283.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse drug reactions | international comparisons | pharmacoepidemiology | qualitative research | regulation

Related Links